文献速递中枢神经肿瘤放疗放疗物理与技术

NBD肽阻断NF-κB减轻幼鼠颅脑放疗后炎症与神经行为后遗症

NF-κB Blockade by NEMO Binding Domain Peptide Ameliorates Inflammation and Neurobehavioral Sequelae After Cranial Radiation Therapy in Juvenile Mice.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-12-09

该研究在28日龄雄性C57BL/6J小鼠中比较假照射、5 Gy全脑放疗及放疗联合NBD肽的效果,发现NBD肽可抑制放疗后NF-κB活化,减轻小胶质细胞与星形胶质细胞活化及TNFα升高,并改善焦虑与探索行为。

要点

  • 5 Gy全脑放疗后4小时NF-κB表达升高,NBD肽可阻断该活化。
  • NBD肽减轻胼胝体与皮质的TNFα、IBA-1和GFAP升高。
  • NBD肽改善放疗3个月后焦虑与探索行为的神经行为评估。

核心结论

  • NBD肽调控NF-κB可减少幼鼠颅脑放疗后的神经炎症并缓解行为并发症。

研究设计与样本

  • 雄性C57BL/6J 28日龄小鼠随机分为生理盐水假照射组、5 Gy全脑放疗组和放疗联合NBD肽组。
  • 放疗后4小时或3个月取脑组织行Western blot或免疫组化,3个月时行旷场与高架十字迷宫行为学评估。

主要发现

  • 放疗后4小时全脑与核组分NF-κB表达升高,NBD处理可阻断该升高。
  • 放疗后细胞死亡增加、增殖减少(包括神经祖细胞),NBD可部分减轻细胞丢失。
  • 放疗后数月胼胝体与皮质TNFα、IBA-1和GFAP水平升高,NBD可限制其升高。
  • NBD肽改善放疗后3个月的焦虑与探索行为评估。

临床怎么用

  • 提示NBD肽抑制NF-κB活化可能作为减轻儿童颅脑放疗神经毒性的候选策略。
  • 临床转化前需进一步验证NBD肽在幼年动物的安全性与长期效果。

局限性

  • 研究为幼鼠动物实验,样本量与统计细节未在摘要中报告。
  • NBD肽的临床适用性、给药方案及长期安全性尚未在摘要中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cranial radiation therapy (CRT) is a common treatment for pediatric brain tumor patients. However, side effects include significant neurobehavioral dysfunction in survivors. This dysfunction may in part be caused by inflammation, including increased production of tumor necrosis factor alpha (TNFα) and its receptor TNFR1, which can activate the nuclear factor kappa light-chain enhancer of activated B cells (NF-κB). The TNFα blockade abrogates this inflammatory response, although it presents immunologic risks. Thus, modulation of pathway subsets may be preferable. Here, we test whether inhibition of NF-κB activation using an NF-κB essential modulator binding domain (NBD) peptide mitigates CRT-induced neuroinflammation and improves behavioral outcomes. METHODS AND MATERIALS: Male C57BL/6J 28-day old mice were randomized to saline (sham), 5 Gy whole-brain CRT, or CRT + NBD-peptide. Brain tissue was collected after 4 hours or 3 months for Western blot or immunohistochemistry. The cortex, corpus callosum (CC), and dentate gyrus were variably imaged for NF-κB-p65, IκBα, proliferation, apoptosis, necroptosis, TNFα, TNFR1, IBA-1, doublecortin, CD11c, and GFAP. Neurobehavioral changes were assessed by open field and elevated plus maze tests 3 months post-CRT. RESULTS: NF-κB expression increased in whole and nuclear fractions 4 hours after CRT and was abrogated by NBD treatment. Cell death increased and proliferation decreased after CRT, including within neuronal progenitors, with some loss mitigated by NBD. Increased levels of TNFα, IBA-1, and GFAP were found in the CC and cortex months after CRT and were limited by NBD. The anti-NF-κB peptide also improved neurobehavioral assessments, yielding improvements in anxiety and exploration. CONCLUSIONS: Results suggest a role for NF-κB modulation by NBD peptide in the reduction of neuroinflammation and mitigation of behavioral complications after pediatric radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Beamish CA, Zawaski JA, Inoue T, et al. NF-κB Blockade by NEMO Binding Domain Peptide Ameliorates Inflammation and Neurobehavioral Sequelae After Cranial Radiation Therapy in Juvenile Mice. Int J Radiat Oncol Biol Phys. 2020. PMID: 33307152. doi:10.1016/j.ijrobp.2020.11.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。